Walid A. Almorsy

Department of Clinical Oncology, Tanta University, Tanta, Egypt

Publications

• Research Article   
  A comparative study between cisplatin weekly versus every 3 weeks concurrently with radiotherapy in the locally advanced head and neck squamous cell carcinomas
  Author(s): Walid A. Almorsy and Neseen M.Sabry*
  
  Background and objectives: Head and neck cancers are vigorous types of cancers and they are considered among the fifth commonest cancer types globally. Among these, squamous cell carcinoma is the commonest. Although advanced treatment in head and neck cancers have been detected, insignificant and unclear improvements in patient survival were revealed. Cisplatin along with radiotherapy is used to increase the sensitivity of radiation in those patients. However, the complete patient’s benefit from cisplatin-based radio-sensitization is unclear which reflects shortage of biomarkers predicting sensitivity. Thus, this study aimed at comparing high and low dose of cisplatin treatment concomitantly administered with radiation therapy regarding safety and efficacy in patients with locally advanced head and neck squamous cell carcinoma. Materials and me.. Read More»
  DOI: 10.4172/1896-8961.16.S1.005

  Abstract HTML PDF